Angiogenesis : a dynamic balance of stimulators and inhibitors

作者: Luisa M Iruela-Arispe , Harold F Dvorak

DOI: 10.1055/S-0038-1657610

关键词:

摘要: Angiogenesis, the formation of new blood vessels from a pre-existing vasculature, is tightly regulated in normal adults. Under physiological circumstances, angiogenesis occurs only few instances; e.g., female reproductive system response to ovulation or gestation, hair cycle, etc. In these examples, growth capillaries controlled by an interplay regulatory proteins which act either stimulate inhibit vessel growth. Normally, balance between forces tipped favor inhibition and consequently capillary restrained. certain pathological however, local inhibitory controls are unable restrain increased activity angiogenic inducers. Thus, wound healing, inflammation tumors, name just integral pathology, engendering hope that entities could be pharmacological and/or genetic suppression (or enhancement) This hope, turn, has fostered interest molecular mechanisms regulate angiogenesis. this chapter, we have reviewed current literature regarding some stimulators inhibitors, emphasizing vascular permeability factor (VPF, also known as endothelial VEGF), major inducer, thrombospondin (TSP) best example natural inhibitor

参考文章(58)
A M Dvorak, V S Harvey, P Estrella, L F Brown, H F Dvorak, J McDonagh, Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Laboratory Investigation. ,vol. 57, pp. 673- 686 ,(1987)
Daniel J. Dumont, Janet Rossant, Ron A Conlon, Terry P. Yamaguchi, Martin L. Breitman, tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors Oncogene. ,vol. 7, pp. 1471- 1480 ,(1992)
M. Detmar, A. M. Dvorak, L. F. Brown, H. F. Dvorak, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology. ,vol. 146, pp. 1029- 1039 ,(1995)
L. F. Brown, M. Detmar, K. Claffey, J. A. Nagy, D. Feng, A. M. Dvorak, H. F. Dvorak, Vascular permeability factor/vascular endothelial growth factor:A multifunctional angiogenic cytokine EXS. ,vol. 79, pp. 233- 269 ,(1997) , 10.1007/978-3-0348-9006-9_10
M. C. Puri, J. Rossant, K. Alitalo, A. Bernstein, J. Partanen, THE RECEPTOR TYROSINE KINASE TIE IS REQUIRED FOR INTEGRITY AND SURVIVAL OF VASCULAR ENDOTHELIAL-CELLS The EMBO Journal. ,vol. 14, pp. 5884- 5891 ,(1995) , 10.1002/J.1460-2075.1995.TB00276.X
A E Canfield, R P Boot-Handford, A M Schor, Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and the substratum Biochemical Journal. ,vol. 268, pp. 225- 230 ,(1990) , 10.1042/BJ2680225
Vishva M. Dixit, Rachel Yabkowitz, Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor Cancer Research. ,vol. 51, pp. 3648- 3656 ,(1991)
V. Joukov, K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk, O. Saksela, N. Kalkkinen, K. Alitalo, A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. The EMBO Journal. ,vol. 15, pp. 290- 298 ,(1996) , 10.1002/J.1460-2075.1996.TB00359.X
L.L. Leung, W.X. Li, J.L. McGregor, G Albrecht, R.J. Howard, CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. Journal of Biological Chemistry. ,vol. 267, pp. 18244- 18250 ,(1992) , 10.1016/S0021-9258(19)37179-0
H.L. Vos, S Devarayalu, Y de Vries, P Bornstein, Thrombospondin 3 (Thbs3), a new member of the thrombospondin gene family. Journal of Biological Chemistry. ,vol. 267, pp. 12192- 12196 ,(1992) , 10.1016/S0021-9258(19)49823-2